Ruta graveolens (Rue)

Ruta graveolens, commonly known as rue, is a Mediterranean herb containing bioactive compounds including rutin and alkaloids that may support cellular health. Research indicates potential neuroprotective effects through MAO-B enzyme inhibition and selective activity against glioblastoma cells.

Origin & History

Ruta graveolens (common rue) is a perennial herbaceous plant native to the Mediterranean region, belonging to the Rutaceae family, and widely cultivated globally for medicinal use. The plant's aerial parts, particularly leaves and stems, are harvested and processed into extracts using methanol, water, or other solvents to capture bioactive compounds including flavonoids, alkaloids, and coumarins.

Historical & Cultural Context

In traditional Chinese medicine, Ruta graveolens treats fever from cold, wind-fire toothache, headache, bruises, and sprains. The herb has been used globally in folk medicine for centuries against various ailments, including traditional anti-tumor and neuroprotective applications.

Health Benefits

• Cancer support: One pilot study (n=31) showed improved quality of life in advanced cancer patients using homeopathic Ruta graveolens 9c (PMID: 25439039) - Preliminary evidence
• Neuroprotective effects: Water extracts selectively killed glioblastoma cells while sparing neurons and inhibited MAO-B in preclinical studies - Animal/in-vitro evidence only
• Liver protection: Demonstrated hepatoprotective effects in rat models by downregulating TGF-β/α-SMA and boosting SOD/CAT antioxidant enzymes - Animal evidence only
• Anti-cancer cell activity: Methanolic extracts induced G₂/M cell cycle arrest and apoptosis in colon, breast, and prostate cancer cells via p53 pathway - In-vitro evidence only
• Antioxidant properties: Contains rutin as the most abundant flavonoid, providing antioxidant effects demonstrated in multiple preclinical studies - In-vitro/animal evidence

How It Works

Ruta graveolens contains rutin, quercetin, and various alkaloids that contribute to its biological activity. The herb's water extracts demonstrate selective cytotoxicity against glioblastoma cells while sparing healthy neurons, and inhibit monoamine oxidase-B (MAO-B) enzyme activity. These mechanisms may contribute to neuroprotective effects and potential therapeutic applications in neurodegenerative conditions.

Scientific Research

Clinical evidence is extremely limited, with only one open-label pilot study (n=31) testing homeopathic Ruta graveolens 9c in advanced cancer patients, showing improved quality of life scores at weeks 8 and 16 (PMID: 25439039). No randomized controlled trials or meta-analyses exist for crude extracts, with remaining evidence derived from preclinical cell culture and animal studies.

Clinical Summary

Clinical research on Ruta graveolens remains limited, with most evidence coming from in vitro studies. One small pilot study (n=31) investigated homeopathic Ruta graveolens 9c in advanced cancer patients, showing improved quality of life measures. Laboratory studies demonstrate selective cytotoxicity against glioblastoma cells and MAO-B inhibition, but human clinical trials are needed to confirm therapeutic efficacy. The current evidence is preliminary and requires further validation through larger, controlled studies.

Nutritional Profile

Ruta graveolens is a bitter aromatic herb with limited consumption as a food due to toxicity concerns, but its phytochemical profile is well-characterized. Macronutrients per 100g fresh herb: protein ~3.5g, carbohydrates ~7g, fiber ~2.5g, fat ~0.6g. Key bioactive compounds include: Alkaloids — arborinine, skimmianine, kokusaginine, and graveoline at trace concentrations (0.01–0.1% dry weight); Flavonoids — rutin (quercetin-3-rutinoside) is the dominant compound at 1.5–2.5% dry weight, one of the highest natural concentrations of rutin among herbs, alongside quercetin (~0.3% dry weight) and kaempferol glycosides; Coumarins and furanocoumarins — bergapten (5-methoxypsoralen), xanthotoxin (8-methoxypsoralen), psoralen, and rutamarin at combined concentrations of 0.2–0.5% dry weight, responsible for photosensitizing effects; Essential oil constituents — 2-undecanone (dominant ketone, ~30–50% of volatile fraction), 2-nonanone, 2-decanone; Acridone alkaloids contributing to MAO-B inhibitory activity; Limonoids including limonin. Micronutrients: Vitamin C (~60–80mg/100g fresh), Vitamin A precursors (beta-carotene), calcium (~100mg/100g), iron (~1.5mg/100g). Bioavailability notes: Rutin has moderate oral bioavailability (~20–30%) enhanced by intestinal hydrolysis to quercetin; furanocoumarins are well-absorbed but activate cytochrome P450 enzymes (CYP3A4 inhibition noted), affecting drug metabolism. Safe culinary use is limited to very small amounts (1–2 fresh leaves) as larger doses are toxic and abortifacient.

Preparation & Dosage

The only clinically studied form was homeopathic Ruta graveolens 9c at 2 mL daily (two 1-mL ampoules) for at least 8 weeks. No clinical dosages exist for crude extracts, powders, or standardized forms. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Rutin, Quercetin, Green tea extract, Milk thistle, Turmeric

Safety & Interactions

Ruta graveolens can cause photosensitivity reactions and skin irritation upon sun exposure due to its furanocoumarins content. The herb is contraindicated during pregnancy as it may stimulate uterine contractions and cause abortion. Large doses can be toxic, causing gastric irritation, confusion, and convulsions. Potential interactions with anticoagulant medications and photosensitizing drugs should be considered before use.